Clinical Trial Update: A Pilot Study of Inflammatory Markers in Alzheimer's Disease [Phase 3]

View source ↗

Summary

A pilot Phase 3 study investigating inflammatory markers in Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: McMaster University | Conditions: Alzheimer's Disease | Phase 3 | Status: UNKNOWN